MARKSANS Intraday Analysis...

MARKSANS Share Price

Open 39.10 Change Price %
High 39.40 1 Day -0.40 -1.02
Low 38.90 1 Week -1.00 -2.50
Close 39.00 1 Month -1.40 -3.47
Volume 657158 1 Year -21.85 -35.91
52 Week High 68.85
52 Week Low 33.50
MARKSANS Important Levels
Resistance 2 39.46
Resistance 1 39.27
Pivot 39.10
Support 1 38.73
Support 2 38.54
NSE INDIA Most Active Stocks
SUZLON 17.50 0.86%
ICICIBANK 257.55 -2.24%
ADANIPOWER 34.75 1.16%
VISESHINFO 0.20 -20.00%
GMRINFRA 12.55 -1.18%
HINDALCO 181.70 5.85%
JPASSOCIAT 10.00 1.52%
AXISBANK 445.00 -1.28%
IDEA 73.35 2.59%
IBREALEST 80.60 -0.86%
More..
NSE INDIA Top Gainers Stocks
BHARATRAS 2279.55 20.00%
PRAKASHSTL 1.80 20.00%
ORIENTHOT 26.75 19.96%
BHAGYNAGAR 25.25 19.95%
OISL 6.05 19.80%
HOVS 161.40 16.03%
KTIL 234.55 12.93%
NAKODA 0.45 12.50%
DLINKINDIA 125.45 11.76%
BLUECHIP 0.50 11.11%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.20 -20.00%
SRGINFOTEC 0.35 -12.50%
HOTELRUGBY 4.10 -11.83%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
SAMTEL 0.50 -9.09%
TECHIN 3.90 -8.24%
More..

Marksans Pharma Limited (NSE: MARKSANS)

MARKSANS Technical Analysis 5
As on 23rd Jan 2017 MARKSANS Share Price closed @ 39.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 45.73 & Strong Sell for SHORT-TERM with Stoploss of 42.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
MARKSANS Target for January
1st Target up-side 44.05
2nd Target up-side 46.99
3rd Target up-side 49.93
1st Target down-side 35.65
2nd Target down-side 32.71
3rd Target down-side 29.77
MARKSANS Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
MARKSANS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.marksanspharma.com
MARKSANS Address
MARKSANS
Lotus Business Park
11th Floor
Mumbai, 400053
India
MARKSANS Latest News
Marksans Pharma jumps 4% on Q3 earnings   Indiainfoline   - 09th Feb 15
Seven foreign pharmaceutical companies forced to stop their business   VietNamNet Bridge   - 29th Jan 15
Bullish on Marksans Pharma in small cap space, Voltas in midcap: Prakash ...   Economic Times   - 12th Nov 14
Marksans Pharma surges on strong Q2 results   Business Standard   - 31st Oct 14
Buy IRB Infra, Burnpur Cement, Marksans Pharma: Pankaj Jain   Moneycontrol.com   - 29th Oct 14
Marksans Pharma up 11%, co likely to be debt free by FY16   Moneycontrol.com   - 23rd Sep 14
Marksans Pharma - Fixes Book Closure for Dividend & AGM (e-voting)   Moneycontrol.com   - 28th Aug 14
Marksans Pharma   Moneycontrol.com   - 30th Jul 14
Marksans Pharma Q3 consolidated net jumps to Rs. 22.48 crore   Equity Bulls   - 15th Feb 14
Breckenridge announces agreement with Marksans Pharma, Ltd. to market ...   PR Newswire (press release)   - 13th Oct 12
Interactive Technical Analysis Chart Marksans Pharma Limited ( MARKSANS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Marksans Pharma Limited
MARKSANS Business Profile
Marksans Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 470.46 crore.The company has reported a consolidated sales of Rs 161.38 crore and a Net Profit of Rs 20.53 crore for the quarter ended Sep 2013.The company management includes Mark Saldanha - Chairman & Managing Director, B S Desai - Whole Time Director, S R Buddharaju - Director, Ajay S Joshi - Director, Naresh Balwant Wadhwa - Ind.& Non Exe.Director. It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.Its Registered office is at 11th Floor, Lotus Business Park,,Off New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Bigshare Services Pvt. Ltd.